Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Prot#CA209010: A Randomized, Blinded, Phase 2 Dose-Ranging Study of BMS-936558 (MDX-1106) in Subjects With Progressive Advanced/Metastatic Clear-Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
Sosman, Jeffrey Alan
(PD/PI)
Kuzel, Timothy Michael
(Other)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
6/21/11
→
6/30/20
Funding
Bristol-Myers Squibb Company
(CA209010)
View all
View less